Recent studies have highlighted a significant weight increase in HIV infected patients who began antiretroviral drugs (ART), particularly dolutegravir (DTG). Aim of the present study was to evaluate predictors of weight gain in DTG treated patients in SCOLTA (Surveillance Cohort Long-Term Toxicity Antiretrovirals) cohort.
Predictors of severe weight gain in patients treated with Dolutegravir
G. F. Pellicanò;
2019-01-01
Abstract
Recent studies have highlighted a significant weight increase in HIV infected patients who began antiretroviral drugs (ART), particularly dolutegravir (DTG). Aim of the present study was to evaluate predictors of weight gain in DTG treated patients in SCOLTA (Surveillance Cohort Long-Term Toxicity Antiretrovirals) cohort.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
